Nasdaq

BD Provides Update on Voluntary Recalls of Alaris(TM) Pump Module Model 8100 and Certain Alaris(TM) Pump Infusion Sets

FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
Seeking Alpha

BD expands recall of its Alaris Pump Module model 8100

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...
Nasdaq

BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error

FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...
Monthly Prescribing Reference

Compatibility Issues Prompt Recall of Alaris Infusion Pumps

To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...
Hosted on MSN

BJC changing IV devices after First Alert 4 Investigation

ST. LOUIS, Mo. (First Alert 4) - A major change at one of the region’s largest hospital systems occurred after a First Alert 4 investigation earlier this month uncovered significant safety concerns ...